Quick Heal Technologies CS Sarang Deshpande resigns for personal reasons

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Sarang Deshpande resigned as Company Secretary of Quick Heal Technologies
  • Resignation cited personal reasons and was submitted on October 19, 2026
  • Last working day is scheduled on or before October 27, 2026
  • Cessation date to be updated per SEBI Regulation 30 guidelines
powered bylight_fuzz_icon
53978250

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies Limited announced that Sarang Deshpande, Company Secretary and Key Managerial Personnel, has tendered his resignation citing personal reasons.

The resignation was submitted on October 19, 2026. The company stated that his last working day will be on or before October 27, 2026. Quick Heal will update the cessation date within the timelines stipulated under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Disclosure details

The company filed an intimation with BSE and NSE regarding the change in Key Managerial Personnel. The disclosure confirmed that the reason for the cessation is resignation due to personal reasons. No other material reasons were provided in the detailed annexure.

Detail Information
Name of KMP Sarang Deshpande
Role Company Secretary
Reason for change Resignation due to personal reasons
Date of cessation On or before October 27, 2026

The filing was signed by Vikram Dhanani, Compliance Officer, on October 19, 2026. The document referenced SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, for the requisite disclosures.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+1.93%+10.02%-3.67%-11.37%-56.39%0.0%

Who will Quick Heal appoint as the interim or permanent successor to Sarang Deshpande, and what is the expected timeline for this transition?

How might this leadership change in a key compliance role impact investor confidence and stock volatility for Quick Heal Technologies?

Are there any pending regulatory filings or corporate governance matters that could be delayed due to the Company Secretary's departure?

Quick Heal Technologies
View Company Insights
View All News
like19
dislike

Quick Heal Technologies passes all resolutions at 31st AGM

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • All four resolutions passed at Quick Heal Technologies' 31st AGM held on September 23, 2026
  • Richard Stiennon re-appointed as Non-Executive Independent Director for a second five-year term starting September 27, 2026
  • Total votes polled stood at 39,052,529, representing 71.96% of outstanding shares
  • Statutory and secretarial audit reports for FY26 contained no qualifications or adverse remarks
powered bylight_fuzz_icon
51709677

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies passed all four resolutions at its 31st Annual General Meeting held on September 23, 2026, with 39,052,529 votes polled, representing 71.96% of total outstanding shares.

The meeting was conducted via Video Conferencing and Other Audio-Visual Means, starting at 11:30 am and concluding at 1:10 pm. A total of 63 members attended the virtual session, comprising 7 from the promoter and promoter group and 56 from the public. The total number of shareholders on the record date of September 17, 2026 stood at 63,195. Chairman Kailash Katkar briefed shareholders on the company's operations, business performance, and key achievements for FY26. Remote e-voting facilities were provided through MUFG Intime India Private Limited from September 19 to September 22, 2026.

Resolutions passed

All four resolutions were approved with requisite majority, as confirmed by the scrutinizer's report submitted on September 24, 2026. The following items were transacted:

Resolution Type Status
Adoption of Financial Statements (Standalone & Consolidated) Ordinary Passed
Appointment of Sanjay Katkar as Director Ordinary Passed
Remuneration to Non-Executive Independent Directors Ordinary Passed
Re-appointment of Richard Stiennon as Independent Director Special Passed

The statutory auditors' report and secretarial auditor report for FY26 did not contain any qualifications, observations, or adverse remarks. Consequently, these reports were not read out during the proceedings.

Detailed voting results

The scrutinizer, Jayavant B. Bhave of J. B. Bhave & Co., Company Secretaries, submitted the consolidated e-voting results covering remote e-voting and e-voting at the AGM. The following tables detail the outcome for each resolution.

Resolution 1: Adoption of financial statements

Category Shares held Votes polled % polled Votes in favour Votes against % in favour % against
Promoter and Promoter Group 38,786,353 38,786,353 100.00 38,786,353 0 100.00 0.00
Public Institutions 226,820 164,763 72.64 164,763 0 100.00 0.00
Public Non Institutions 15,260,407 101,413 0.66 101,201 212 99.79 0.21
Total 54,273,580 39,052,529 71.96 39,052,317 212 100.00 0.00

Resolution 2: Appointment of Sanjay Katkar as director

Category Shares held Votes polled % polled Votes in favour Votes against % in favour % against
Promoter and Promoter Group 38,786,353 38,786,353 100.00 38,786,353 0 100.00 0.00
Public Institutions 226,820 164,763 72.64 151,631 13,132 92.03 7.97
Public Non Institutions 15,260,407 101,413 0.66 101,150 263 99.74 0.26
Total 54,273,580 39,052,529 71.96 39,039,134 13,395 99.97 0.03

Resolution 3: Remuneration to non-executive independent directors

Category Shares held Votes polled % polled Votes in favour Votes against % in favour % against
Promoter and Promoter Group 38,786,353 38,786,353 100.00 38,786,353 0 100.00 0.00
Public Institutions 226,820 164,763 72.64 164,763 0 100.00 0.00
Public Non Institutions 15,260,407 101,153 0.66 100,603 550 99.46 0.54
Total 54,273,580 39,052,269 71.95 39,051,719 550 100.00 0.00

Resolution 4: Re-appointment of Richard Stiennon as non-executive independent director

Category Shares held Votes polled % polled Votes in favour Votes against % in favour % against
Promoter and Promoter Group 38,786,353 38,786,353 100.00 38,786,353 0 100.00 0.00
Public Institutions 226,820 164,763 72.64 152,125 12,638 92.33 7.67
Public Non Institutions 15,260,407 101,413 0.66 100,572 841 99.17 0.83
Total 54,273,580 39,052,529 71.96 39,039,050 13,479 99.97 0.03

Director appointment details

Shareholders approved the re-appointment of Richard Stiennon as Non-Executive Independent Director for a second term of five consecutive years, effective from September 27, 2026, to September 26, 2031. Stiennon is the Chief Research Analyst at ITHarvest, a firm he founded in 2005, and serves on the advisory board of several startups. He is the author of Security Yearbook 2025 and Guardians of the Machine Age, among other publications on cybersecurity and digital defense. He holds a Bachelor of Science in Aerospace Engineering and an MA in War in the Modern World from King's College, London. The company confirmed that Stiennon is not related to any other director and is not debarred from holding office by SEBI or any other authority.

Management updates

Management provided an overview of the global cybersecurity landscape and the evolving threat environment. The presentation outlined the company's approach to strengthening cybersecurity measures and protecting customers. Key areas discussed included product development, business transformation, marketing strategies, people and culture initiatives, and overall growth opportunities in the cybersecurity market. Shareholders raised queries regarding operations, business performance, and growth strategy, which the Chairman and management team addressed to the satisfaction of attendees.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+1.93%+10.02%-3.67%-11.37%-56.39%0.0%

How will the appointment of Sanjay Katkar as Director influence Quick Heal's strategic direction and succession planning for the promoter group?

What specific product development or market expansion initiatives were highlighted in the FY26 performance briefing that could drive future revenue growth?

Given the low institutional voting turnout, how might Quick Heal improve shareholder engagement and institutional investor confidence in upcoming quarters?

Quick Heal Technologies
View Company Insights
View All News
like17
dislike

More News on Quick Heal Technologies

1 Year Returns:-56.39%